Leptospirosis and COVID-19 Co-Infection Manifesting as an Enhanced Thrombotic Phenomenon

Yudhyavir Singh, Abhishek Singh, Kapildev Soni, Anjan Trikha

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Clinical manifestations of coronavirus disease 2019 (COVID-19) range from mild self-limiting illness to multi-organ dysfunction and acute respiratory distress syndrome (ARDS). Also, leptospirosis manifests as mild or asymptomatic infection, and only a small number of patients progress to ARDS and develop systemic manifestation. COVID-19 and leptospira co-infection can have fatal outcomes because of augmented pathophysiological manifestations of both the disease.

Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
JournalJournal of Cellular and Molecular Anesthesia
Volume7
Issue number2
DOIs
StatePublished - Apr 1 2022

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Leptospirosis and COVID-19 Co-Infection Manifesting as an Enhanced Thrombotic Phenomenon'. Together they form a unique fingerprint.

Cite this